Integra LifeSciences has received FDA clearance for their Camino Flex Ventricular Catheter. This catheter is designed to be used with Integra’s Camino Monitor which was approved last year and is already used in over 800 centers across the United States. This device is used with magnetic resonance imaging (MRI scans) and gives clinicians a more advanced system that can monitor ICP independently even when CSF flow cannot be measured, unlike competing catheters which depend on CSF flow. Integra is not new to the neurosurgery industry, but has an already existing product line that consists of: cranial access kits and CSF drainage systems. Their neurosurgery product line is their second largest segment, next to orthopedics, and reported $278,992 in fourth quarter revenue in 2013 coming from their neurosurgery segment. This figure represents approximately one third of their total revenue for the respected quarter.